Skip to content

The AMD Experts

50196296_795957517416981_458178117475762176_n

Our Team

The MacuLogix team is committed to empowering primary eye care professionals with the technology and tools needed to create AMD Centers of Excellence®.

Bill McPhee, the President and CEO of MacuLogix, shares his personal story of why he joined the company and adopted its vision of eliminating blindness caused by AMD.

The AdaptDx is especially useful for optometrists and general ophthalmologists who see many patients with “normal” clinical exams, since it can detect subclinical AMD up to three years before clinical onset. With the AdaptDx, you will be in the front line in detecting these patients and will be able to carefully monitor and treat those with subclinical AMD.

Dr. Shawn Lewis1 Shawn Lewis, MD View all testimonials

Latest News & Upcoming Events

View More
Article: September 17, 2019 | Women in Optometry

Ability to Quantify AMD Changes Is a Game-Changer

The AdaptDx is changing the way Dr. Donna Shotwell and many other eye care professionals manage their AMD patients.

Article: September 2019 | Modern Optometry

Sharpen Your AMD Diagnostic Skills

"Know how to spot early AMD, and have a plan of action," says Dr. Damon Dierker of Eye Surgeons of Indiana.

Blog: September 10, 2019

Do You Know Your ABCs…of AMD (Age-Related Macular Degeneration)?

Preserving your vision from AMD can be as simple as ABC according to our Senior VP of Global Sales, Armond Dantino.

Put Our Expertise to Work

Testing with AdaptDx

AdaptDx identifies impaired dark adaptation—the earliest warning sign of AMD.

Guiding AdaptDx Implementation

Each AdaptDx purchase is supported by our AMD Excellence Program™ to help you achieve your patient care and practice revenue goals.